May 13 |
Nexalin Technology First Quarter 2024 Earnings: US$0.14 loss per share (vs US$0.10 loss in 1Q 2023)
|
May 9 |
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on May 23
|
Apr 25 |
Nexalin Technology regains compliance with Nasdaq continued listing requirements
|
Apr 25 |
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
|
Apr 16 |
Nexalin Technology files to offer common stock worth $5.65M
|
Apr 10 |
Nexalin Technology CEO Provides Letter to Shareholders
|
Apr 9 |
Nexalin Technology Accelerates Manufacturing of its HALO™ Clarity Following Successful Usability, Feasibility, and Electrical Testing
|
Apr 4 |
Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device
|
Apr 4 |
Nexalin Technology unveils positive results of clinical study for Gen-2 tACS device
|
Apr 2 |
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
|